New Insights into Treatments Across the Lifespan

Ned H Kalin,Ned H. Kalin

DOI: https://doi.org/10.1176/appi.ajp.20240051

IF: 17.7

2024-03-03

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 3, Page 171-174, March 01, 2024.

psychiatry

What problem does this paper attempt to address?

Improving Clinical Outcomes and Informing New Interventions

Ned H. Kalin

DOI: https://doi.org/10.1176/appi.ajp.20230929

IF: 17.7

2024-01-03

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 1, Page 1-3, January 01, 2024.

psychiatry
Advances in Understanding Schizophrenia, ADHD, and ASD

Ned H. Kalin

DOI: https://doi.org/10.1176/appi.ajp.20240325

IF: 17.7

2024-06-02

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 6, Page 461-464, June 01, 2024.

psychiatry
New Developments in Understanding and Treating Opiate and Cannabis Use Disorders

Ned H. Kalin

DOI: https://doi.org/10.1176/appi.ajp.20231018

IF: 17.7

2024-02-03

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 2, Page 83-86, February 01, 2024.

psychiatry
Depression: Factors Contributing to Risk and Therapeutic Insights

Ned H. Kalin

DOI: https://doi.org/10.1176/appi.ajp.20240648

IF: 17.7

2024-09-03

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 9, Page 777-780, September 01, 2024.

psychiatry
Schizophrenia Spectrum Disorders and Psychosis

Ned H. Kalin

DOI: https://doi.org/10.1176/appi.ajp.20240733

IF: 17.7

2024-10-03

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 10, Page 847-850, October 01, 2024.

psychiatry
Homelessness, Discrimination, PTSD, Autism, and the Amygdala

Ned H. Kalin

DOI: https://doi.org/10.1176/appi.ajp.20240975

IF: 17.7

2024-12-03

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 12, Page 1029-1032, December 01, 2024.

psychiatry
New understandings meet old treatments: putting a contemporary face on established protocols

Susan M. Byrne,Anthea Fursland

DOI: https://doi.org/10.1186/s40337-024-00983-4

2024-02-11

Journal of Eating Disorders

Abstract:In the twenty years since the publication of the most widely used treatment manuals describing evidence-based therapies for eating disorders, there have been some substantial advances in the field. New methods of delivering treatments have been trialled and our perception of mental health has advanced; significant cultural changes have led to shifts in our societal landscape; and new technologies have allowed for more in-depth research to be conducted. As a result, our understanding of eating disorders and their treatment has broadened considerably. However, these new insights have not necessarily been translated into improved clinical practice. This paper highlights the changes we consider to have had the greatest impact on our work as experienced clinical psychologists in the field and suggests a list of new learnings that might be incorporated into clinical practice and research design.

psychiatry,nutrition & dietetics,psychology, clinical
Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II

Yehong Fang,Yi Liu,Ling Li,Dara G. Ghahremani,Jianhua Chen,Kyoji Okita,Wenbin Guo,Yanhui Liao

DOI: https://doi.org/10.3389/fpsyt.2023.1134561

IF: 4.7

2023-01-01

Frontiers in Psychiatry

Abstract:EDITORIAL article Front. Psychiatry, 13 April 2023Sec. Addictive Disorders Volume 14 - 2023 | https://doi.org/10.3389/fpsyt.2023.1134561
A History of Child and Adolescent Treatment Through a Distillation Lens: Looking Back to Move Forward

Kelsie H Okamura,Trina E Orimoto,Brad J Nakamura,Bree Chang,Bruce F Chorpita,Rinad S Beidas

DOI: https://doi.org/10.1007/s11414-019-09659-3

Abstract:Youth psychosocial treatments have proliferated over many decades and the time is ripe to examine the unique contribution of these treatments. Six hundred eighty-nine randomized clinical trials were examined from the PracticeWise Evidence-Based Services Database, an ongoing data source of youth psychosocial literature. A number of studies, treatment protocols, and practice elements across 11 youth problem areas (e.g., anxiety) from 1966 to 2016 are provided. Using distillation methodology, we compared the relationship between new treatment protocols and the identification of new practice elements within each problem area over time. Anxiety, disruptive behavior, attention/hyperactivity, and depression were the most studied problem areas, whereas suicide, eating disorders, and mania were least studied. While identification of new practice elements leveled off, studies continued to increase over time. For some problem areas, unique practice elements have not been identified for over a decade. Future studies examining treatment innovation and implications for behavioral health are discussed.
Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment

Andrew D Geoly,Ian H Kratter,Pouya Toosi,Eleanor J Cole,Gregory L Sahlem,Nolan R Williams,Andrew D. Geoly,Ian H. Kratter,Eleanor J. Cole,Gregory L. Sahlem,Nolan R. Williams

DOI: https://doi.org/10.1176/appi.ajp.20230113

IF: 17.7

2024-01-03

American Journal of Psychiatry

Abstract:American Journal of Psychiatry, Volume 181, Issue 1, Page 71-73, January 01, 2024.

psychiatry
Dr. Carpenter and Associates Reply

WILLIAM T. CARPENTER,THOMAS H. McGLASHAN,JOHN S. STRAUSS

DOI: https://doi.org/10.1176/ajp.134.6.700

IF: 17.7

1977-01-01

American Journal of Psychiatry

Abstract:Back to table of contents Previous article Next article ArticleNo AccessDr. Carpenter and Associates ReplyWILLIAM T. CARPENTER JR., THOMAS H. McGLASHAN, and JOHN S. STRAUSSWILLIAM T. CARPENTER JR., THOMAS H. McGLASHAN, and JOHN S. STRAUSSPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.134.7.819-aAboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "Dr. Carpenter and Associates Reply." American Journal of Psychiatry, 134(7), pp. 819-a–820 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Register for access Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byThe Long-Term Effects of Antipsychotic Medication on Clinical Course in SchizophreniaDonald C. Goff, M.D., Peter Falkai, M.D., Ph.D., W. Wolfgang Fleischhacker, M.D., Ragy R. Girgis, M.D., Rene M. Kahn, M.D., Ph.D., Hiroyuki Uchida, M.D., Ph.D., Jingping Zhao, M.D., Ph.D., Jeffrey A. Lieberman, M.D.5 May 2017 | American Journal of Psychiatry, Vol. 174, No. 9The Psychology of SchizophreniaJournal of Nervous & Mental Disease, Vol. 204, No. 8Predicting Medication-Free Treatment Response in Acute PsychosisJournal of Nervous & Mental Disease, Vol. 194, No. 10Antipsychotic Drugs: When and How to Withdraw Them?21 April 2006 | Psychotherapy and Psychosomatics, Vol. 75, No. 3Is There an Association Between Duration of Untreated Psychosis and 24-Month Clinical Outcome in a First-Admission Series?Thomas J. Craig, M.D., Evelyn J. Bromet, Ph.D., Shmuel Fennig, M.D., Marsha Tanenberg-Karant, M.D., Janet Lavelle, M.S., and Nora Galambos, Ph.D.1 January 2000 | American Journal of Psychiatry, Vol. 157, No. 1Nordic Journal of Psychiatry, Vol. 50, No. 4Continuous versus targeted medication in schizophrenic outpatients: outcome results [published erratum appears in Am J Psychiatry 1991 Jun;148(6):819]1 April 2006 | American Journal of Psychiatry, Vol. 147, No. 9Psychiatric Quarterly, Vol. 58, No. 1Paraprofessionals and Psychiatric Teams: An Updated ReviewH. Steven Moffic, Guy K. Patterson, Ramon Laval, and George L. Adams1 April 2006 | Psychiatric Services, Vol. 35, No. 1Journal of Community Psychology, Vol. 11, No. 3Acta Psychiatrica Scandinavica, Vol. 65, No. S298Training vocational rehabilitation counselors who work with chronic mental patients1 April 2006 | American Journal of Psychiatry, Vol. 138, No. 8Does attitude toward psychosis relate to outcome?1 April 2006 | American Journal of Psychiatry, Vol. 138, No. 6Methodologic standards for treatment outcome research in schizophrenia1 April 2006 | American Journal of Psychiatry, Vol. 138, No. 4Menopausal syndrome: Illness or social role ? A transcultural analysisCulture, Medicine and Psychiatry, Vol. 4, No. 3Research on the psychosocial treatment of schizophrenia: a summary report1 April 2006 | American Journal of Psychiatry, Vol. 136, No. 5Culture, Medicine and Psychiatry, Vol. 3, No. 3Community Residential Treatment for Schizophrenia: Two-Year Follow-upLoren R. Mosher, and Alma Z. Menn1 April 2006 | Psychiatric Services, Vol. 29, No. 11Dr. Tarsy RepliesDANIEL TARSY1 April 2006 | American Journal of Psychiatry, Vol. 135, No. 5Journal of Psychedelic Drugs, Vol. 10, No. 1 Volume 134Issue 7 July 1977Pages 819-a-820 Metrics PDF download History Published online 1 April 2006 Published in print 1 July 1977
New Horizons in Pediatric Psychopharmacology

Sarah Khan,Vijaylaxmi Rathore,Shahida Khan

DOI: https://doi.org/10.1002/ddr.21333

Abstract:Preclinical Research Recent advances in pediatric psychopharmacology have been rather uneven. Increased use of psychotropic drugs among the pediatric population has raised concerns regarding their inappropriate use and safety. While clinical trials have been conducted on various pediatric psychopharmacological drugs, there has been an insignificant amount of importance to innovation in holistic treatment. A rational approach toward elucidating the various challenges would be contingent on the convergence of the development of novel efficacious psychotropic drugs with concrete conceptual frameworks and guidelines fostering enhanced outcomes. A research infrastructure concerning the relevance of the clinician's perspective, combining drugs with alternative therapies, the need for pediatric specific formulations and relevance of these in developing countries provides a basis on which innovative treatment/development can be constructed. The current commentary highlights these comprehensive and targeted treatment guidelines as aspects necessary for building the future of the field. Drug Dev Res 77 : 474-478, 2016. © 2016 Wiley Periodicals, Inc.
Contents of the American Journal of Psychiatry

Carroll W. Hughes,John J. McGrath,Debbie A. Lawlor,Fritz A. Henn,Robert Freedman,David Lewis,Robert Michels,Silke Wiegand‐Grefe,Susan K. Schultz,Carol Tamminga,Benjamin D. Brody,Andrew C. Leon,James H. Kocsis,Jehanny Alcon,Kimberly Glazier,Carolyn I. Rodríguez,Samuel Law,Pozi Liu,Brian Hodges,Wes Shera,Xuchen Huang,Juveria Zaheer,Paul S. Links,Bronwyn M. Graham,Mohammed R. Milad,Kelly Posner,Gregory K. Brown,Barbara Stanley,David A. Brent,Kseniya Yershova,María A. Oquendo,Glenn W. Currier,Glenn Melvin,Laurence L. Greenhill,Sa Shen,J. John Mann,Wim Veling,Hans W. Hoek,Jean-Paul Selten,Ezra Susser,Manuela Heins,Claudia Simons,Tineke Lataster,Stefanie Pfeifer,Dagmar Versmissen,M. Lardinois,Machteld Marcelis,Philippe Delespaul,Lydia Krabbendam,Jim van Os,Inez Myin,Mary Clarke,Antti Tanskanen,Matti Huttunen,David A. Leon,Robin Murray,Peter Jones,Mary Cannon,Michael E. Benros,Philip Nielsen,Merete Nordentoft,William W. Eaton,Susanne Oksbjerg Dalton,Preben Bo Mortensen,Oliver Howes,Subrata K. Bose,Federico Turkheimer,Isabel Valli,Alice Egerton,Lucia Valmaggia,Philip McGuire,Ming Li,Xlong-Jlan Luo,Xiao,Lei Shi,Xingyan Liu,L.X. Yin,Hong-Bo Diao,Bing Su,Zhishun Wang,Tiago V. Maia,Rachel Paskell,Tiziano Colibazzi,Andrew J. Gerber,Bradley Peterson

DOI: https://doi.org/10.1192/s0007125000288624

2012-01-01

The British Journal of Psychiatry

Abstract:An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Developing Treatments for Antisocial Behavior Among Children: Controlled Trials and Uncontrolled Tribulations

Alan E Kazdin

DOI: https://doi.org/10.1177/1745691618767880

Abstract:The article describes my research on the development and evaluation of psychosocial treatments for children who engage in extremes of antisocial behavior (e.g., aggression, property destruction, theft). I begin with my "story" of how the focus on interventions started as I worked in various settings (rehabilitation facilities, schools, hospitals, and outpatient clinical services) and with children, adolescents, and adults. The main stream of treatment research and findings with antisocial child behavior is highlighted along with tributaries that led naturally from the outcome research. Our trials are complemented by tribulations that apply to evidence-based psychosocial interventions more broadly. Most individuals in need of psychological services in the United States and worldwide receive no treatment. Much can be done right now with novel models of treatment delivery that draw on multiple disciplines (e.g., public health, business, entertainment, economics, robotics and artificial intelligence, and law and social policy). More research on interventions that do not or cannot reach most people in need is quite limited in value to me. Finally (and belatedly) my attention has turned to ways of exerting impact, and for that, evidence-based interventions are necessary but hardly sufficient.
Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies

Anitha K,Mandeep Kumar Singh,Komal Kohat,Sri Varshini T,Santenna Chenchula,Padmavathi R,Lakshmi Sahitya Amerneni,Vishnu Vardhan K,Mythili Bai K,Madhav Rao Chavan,Shvetank Bhatt

DOI: https://doi.org/10.1007/s12035-024-04384-1

2024-08-05

Abstract:In recent years, significant advancements have been made in understanding Alzheimer's disease from both neurobiological and clinical perspectives. Exploring the complex systems underlying AD has unveiled insights that could potentially revolutionize therapeutic approaches. Recent investigations have highlighted intricate interactions among genetic, molecular, and environmental factors in AD. Optimism arises from neurobiological advancements and diverse treatment options, potentially slowing or halting disease progression. Amyloid-beta plaques and tau protein tangles crucially influence AD onset and progression. Emerging treatments involve diverse strategies, such as approaches targeting multiple pathways involved in AD pathogenesis, such as inflammation, oxidative stress, and synaptic dysfunction pathways. Clinical trials using humanized monoclonal antibodies, focusing on immunotherapies eliminating amyloid-beta, have shown promise. Nonpharmacological interventions such as light therapy, electrical stimulation, cognitive training, physical activity, and dietary changes have drawn attention for their potential to slow cognitive aging and enhance brain health. Precision medicine, which involves tailoring therapies to individual genetic and molecular profiles, has gained traction. Ongoing research and interdisciplinary collaboration are expected to yield more effective treatments.
Innovative solutions to novel drug development in mental health.

T R Insel,V Voon,J S Nye,V J Brown,B M Altevogt,E T Bullmore,G M Goodwin,R J Howard,D J Kupfer,G Malloch,H M Marston,D J Nutt,T W Robbins,S M Stahl,M D Tricklebank,J H Williams,B J Sahakian

DOI: https://doi.org/10.1016/j.neubiorev.2013.03.022

IF: 9.052

2013-01-01

Neuroscience & Biobehavioral Reviews

Abstract:•New approaches to identifying and validating potential drug targets are essential.•A novel drug toolbox and innovative private-public partnerships are required.•Translational neuroscience research will enhance understanding of mental health.•The training of a new cadre of clinician scientists is a necessary foundation.•Neuropsychiatric disorders require holistic, early, effective treatment.
SPARKing New Insight Into Autism Across the Lifespan

Khemika K Sudnawa,Wendy K Chung,Khemika K. Sudnawa,Wendy K. Chung

DOI: https://doi.org/10.1352/1944-7558-129.2.91

2024-02-27

American Journal on Intellectual and Developmental Disabilities

Abstract:Abstract Autism is heterogeneous at many levels, including clinical symptoms and etiology. A key strategy in studying heterogeneous conditions is having large enough sample sizes to stratify into smaller groups that are more homogeneous. SPARK and Simons Searchlight are large and growing research cohorts of individuals with autism in the United States and individuals with genetically defined neurodevelopmental conditions around the world, respectively. They both provide freely available phenotypic and genotypic data with the ability to re-contact participants through the research match program. Deep dives into each gene in Searchlight provide comprehensive natural history data to understand the differing clinical courses to inform proper clinical care, and work toward treatment for each condition. Moreover, pilots of genetically based newborn screening programs for neurogenetic disorders can provide opportunities for equitable and early diagnosis to try to improve outcomes with earlier interventions.

rehabilitation,education, special
Journal abstracts from current research in the field of child and adolescent mental health

Erhabor S Idemudia

DOI: https://doi.org/10.2989/17280583.2011.594292

2011-08-14

Journal of Child and Adolescent Mental Health

Abstract:Gonzales NA, Coxe S, Roosa MW, White RMB, Knight GP, Zeiders KH and Saenz D (2011) Economic hardship, neighborhood context, and parenting: Prospective effects on Mexican-American adolescent's mental health. American Journal of Community Psychology 47(1-2): 98-113 O'Kane D (2011) A phenomenological study of child and adolescent mental health consultation in primary care. Journal of Psychiatric and Mental Health Nursing 18(2): 185-188 Sentse M, Ormel J, Veenstra R, Verhulst FC and Oldehinkel AJ (2011) Child temperament moderates the impact of parental separation on adolescent mental health: The trails study. Journal of Family Psychology 25(1): 97-106 Leo RJ, Srinivasan SP and Parekh S (2011) The role of the mental health practitioner in the assessment and treatment of child and adolescent chronic pain. Child and Adolescent Mental Health 16(1): 2-8 James AC, Winmill L, Anderson C and Alfoadari K (2011) A preliminary study of an extension of a community dialectic behaviour therapy (DBT) programme to adolescents in the looked after care system. Child and Adolescent Mental Health 16(1): 9-13 Flouri E, Hickey J, Mavroveli S and Hurry J (2011) Adversity, emotional arousal, and problem behaviour in adolescence: The role of non-verbal cognitive ability as a resilience promoting factor. Child and Adolescent Mental Health 16(1): 22-29 Paradis AD, Giaconia RM, Reinherz HZ, Beardslee WR, Ward KE and Fitzmaurice GM (2011) Adolescent family factors promoting healthy adult functioning: A longitudinal community study. Child and Adolescent Mental Health 16(1): 30-37 Webster-Stratton C, Rinaldi J and Reid JM (2011) Long-term outcomes of Incredible Years parenting program: Predictors of adolescent adjustment. Child and Adolescent Mental Health 16(1): 38-46 Baruch G, Vrouva I and Wells C (2011) Outcome findings from a parent training programme for young people with conduct problems. Child and Adolescent Mental Health 16(1): 47-54 Davis Kenaley BL and Williams NJ (2011) A preliminary evaluation: Demographic and clinical profiles and changes in functioning in children receiving psychosocial rehabilitation. Children and Youth Services Review 33(2): 301-307.
Neuorpsychiatyric Applications of CANTAB

PJ Fray,TW Robbins,BJ Sahakian

DOI: https://doi.org/10.1002/(sici)1099-1166(199604)11:4<329::aid-gps453>3.0.co;2-6

1996-01-01

International Journal of Geriatric Psychiatry

Abstract:International Journal of Geriatric PsychiatryVolume 11, Issue 4 p. 329-336 Research Article Neuorpsychiatyric applications of CANTAB Paul J. Fray, Paul J. Fray Cambridge Cognition, Cambridge, UKSearch for more papers by this authorTrevor W. Robbins, Trevor W. Robbins University of Cambridge, Dept of Experimental Psychology, Cambridge, UKSearch for more papers by this authorBarbara J. Sahakian, Corresponding Author Barbara J. Sahakian University of Cambridge, School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UKUniversity of Cambridge, School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK. Tel: +44 1223 336965. Fax +44 1223 336968.Search for more papers by this author Paul J. Fray, Paul J. Fray Cambridge Cognition, Cambridge, UKSearch for more papers by this authorTrevor W. Robbins, Trevor W. Robbins University of Cambridge, Dept of Experimental Psychology, Cambridge, UKSearch for more papers by this authorBarbara J. Sahakian, Corresponding Author Barbara J. Sahakian University of Cambridge, School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UKUniversity of Cambridge, School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK. Tel: +44 1223 336965. Fax +44 1223 336968.Search for more papers by this author First published: April 1996 https://doi.org/10.1002/(SICI)1099-1166(199604)11:4<329::AID-GPS453>3.0.CO;2-6Citations: 183AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume11, Issue4April 1996Pages 329-336 RelatedInformation
Network‐based artificial intelligence approaches for advancing personalized psychiatry

Sivanesan Rajan,Emanuel Schwarz

DOI: https://doi.org/10.1002/ajmg.b.32997

2024-06-23

American Journal of Medical Genetics Part B Neuropsychiatric Genetics

Abstract:American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.

genetics & heredity,psychiatry

New Insights into Treatments Across the Lifespan

Improving Clinical Outcomes and Informing New Interventions

Advances in Understanding Schizophrenia, ADHD, and ASD

New Developments in Understanding and Treating Opiate and Cannabis Use Disorders

Depression: Factors Contributing to Risk and Therapeutic Insights

Schizophrenia Spectrum Disorders and Psychosis

Homelessness, Discrimination, PTSD, Autism, and the Amygdala

New understandings meet old treatments: putting a contemporary face on established protocols

Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II

A History of Child and Adolescent Treatment Through a Distillation Lens: Looking Back to Move Forward

Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment

Dr. Carpenter and Associates Reply

New Horizons in Pediatric Psychopharmacology

Contents of the American Journal of Psychiatry

Developing Treatments for Antisocial Behavior Among Children: Controlled Trials and Uncontrolled Tribulations

Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies

Innovative solutions to novel drug development in mental health.

SPARKing New Insight Into Autism Across the Lifespan

Journal abstracts from current research in the field of child and adolescent mental health

Neuorpsychiatyric Applications of CANTAB

Network‐based artificial intelligence approaches for advancing personalized psychiatry